The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Glossary Glossary

Genvoya (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide)

The Details

Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) is a multi-class combination drug used to treat HIV/AIDS. It is approved by the U.S. FDA for the treatment of HIV infection in people ages 12 and above. It is listed in the HHS HIV treatment guidelines as a recommended regimen for people starting HIV treatment for the first time.


Adult single dose: Take one tablet once daily. Each tablet contains 150 mg of elvitegravir, 150 mg of cobicistat, 200 mg of emtricitabine and 10 mg of tenofovir alafenamide.


  • Take with food.
  • Genvoya should not be taken in combination with other anti-HIV medicines.
  • Women should not breastfeed while on Genvoya.
The Basics

  • Email Email
  • Glossary Glossary

The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.